Stock & Company Details
ElectroCore Inc $ECOR
Price:
46,691,331
8.3M
$72M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-2.36
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
ECOR technical indicators
Latest ElectroCore Inc (ECOR) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
49.70 5.7%
MACD:
-0.00 193.3%
SMA 50:
$7.72 0.5%
SMA 200:
$6.21 0.3%
EMA 20:
$8.40 0.1%
Bollinger Bands:
10.62 / 7.09
Stochastic:
40.54 11.7%
ADX 14:
17.25 4.5%
ATR 14:
0.91 0.1%
CCI 20:
-40.49 14.5%
OBV:
2.79M 3.9%
ROC 12:
-19.02% 25.8%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients. The gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache, Bronchoconstriction and Medication Overuse Headache in adults.
Finance Bot
Ask your questions
Start by typing a question below.
